Evidence map›Paper›PMID 26116518›Full record

ReviewNeuroscience2015

The ins and outs of the striatum: role in drug addiction.

L M Yager, A F Garcia, A M Wunsch, S M Ferguson

Abstract readReview
In one paragraph

Review in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 225 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
225citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

225 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Observational
  14. Central amygdalar PKCδ neurons mediate fentanyl withdrawal.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  15. Article
  16. Article
  17. The active construction of past episodes.Translational neuroscience · 2026
    Article
  18. Article
  19. Review
  20. Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article

165 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

L M YagerCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
A F GarciaCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States; Neuroscience Graduate Program, University of Washington, Seattle, WA, United States.
A M WunschCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States; Neuroscience Graduate Program, University of Washington, Seattle, WA, United States.
S M FergusonCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States; Neuroscience Graduate Program, University of Washington, Seattle, WA, United States; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States. Electronic address: smfergus@uw.edu.

Funding

TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGST32DA007278 · NIDA · UNIVERSITY OF WASHINGTON · PI Susan Marie Ferguson, Paul E. M. Phillips · 1993 to 2026
$9.8M
Role of specific cortico-basal ganglia pathways in animal models of addictionR01DA036582 · NIDA · SEATTLE CHILDREN'S HOSPITAL · PI FERGUSON, SUSAN MARIE · 2014 to 2018
$2.3M
NIDA NIH HHS R01 DA036582NIDA NIH HHS R01DA036582NIDA NIH HHS T32 DA007278NIDA NIH HHS T32DA007278
6 · The paper itself

Abstract

Addiction is a chronic relapsing disorder characterized by the loss of control over drug intake, high motivation to obtain the drug, and a persistent craving for the drug. Accumulating evidence implicates cellular and molecular alterations within cortico-basal ganglia-thalamic circuitry in the development and persistence of this disease. The striatum is a heterogeneous structure that sits at the interface of this circuit, receiving input from a variety of brain regions (e.g., prefrontal cortex, ventral tegmental area) to guide behavioral output, including motor planning, decision-making, motivation and reward. However, the vast interconnectivity of this circuit has made it difficult to isolate how individual projections and cellular subtypes within this circuit modulate each of the facets of addiction. Here, we review the use of new technologies, including optogenetics and DREADDs (Designer Receptors Exclusively Activated by Designer Drugs), in unraveling the role of the striatum in addiction. In particular, we focus on the role of striatal cell populations (i.e., direct and indirect pathway medium spiny neurons) and striatal dopaminergic and glutamatergic afferents in addiction-related plasticity and behaviors.

Indexed as

AnimalsCorpus StriatumDopamineGlutamic AcidHumansNerve NetSubstance-Related DisordersDopamineGlutamic Acidaddictionbasal gangliacortexDREADDsoptogeneticsstriatum

Identifiers

PMID26116518
PMCPMC4523218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.